Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 13;68(49):1142-1148.
doi: 10.15585/mmwr.mm6849e1.

Update: Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, December 2019

Matthew J Lozier, Bailey Wallace, Kayla Anderson, Sascha Ellington, Christopher M Jones, Dale Rose, Grant Baldwin, Brian A King, Peter Briss, Christina A Mikosz; Lung Injury Response Epidemiology/Surveillance Task Force
Collaborators, Affiliations

Update: Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, December 2019

Matthew J Lozier et al. MMWR Morb Mortal Wkly Rep. .

Erratum in

  • Erratum: Vol. 68, No. 49.
    [No authors listed] [No authors listed] MMWR Morb Mortal Wkly Rep. 2020 Jan 31;69(4):117. doi: 10.15585/mmwr.mm6904a7. MMWR Morb Mortal Wkly Rep. 2020. PMID: 31999687 Free PMC article. No abstract available.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE 1
FIGURE 1
Number of patients (N = 2,163) with lung injury associated with e-cigarette, or vaping, product use, by week of hospital admission and percentage of patients hospitalized in last 3 weeks — United States, February 10–December 3, 2019 * Percentage hospitalized within 3 weeks preceding the date reported to CDC.
FIGURE 2
FIGURE 2
Prevalence of hospitalized cases of e-cigarette, or vaping, product use–associated lung injury (N = 2,291) — United States, August–December 2019 The figure is a U.S. map, showing the prevalence (cases per 1 million) of hospitalized or deceased cases of e-cigarette, or vaping, product use–associated lung injury during August–December 2019. Abbreviations: DC = District of Columbia; PR = Puerto Rico; VI = U.S. Virgin Islands. * Number of cases per 1 million population. The U.S. Census population from 2010 was used to calculate prevalence for U.S. Virgin Islands, and U.S. Census population estimates from 2018 were used to calculate prevalence for all other states, the District of Columbia, and territories.
FIGURE 3
FIGURE 3
Percentage of hospitalized EVALI patients (N = 482) who reported brand names of THC-containing e-cigarettes, or vaping, products, by U.S. Census region — United States, August–December 2019 Abbreviations: EVALI = e-cigarette, or vaping, product use–associated lung injury; THC = tetrahydrocannabinol. “Other products” included 146 unique products. Dabwood and Brass Knuckles were reported by 10% of patients in the Northeast and West regions. Off White, Moon Rocks, Chronic Carts, Mario Carts, Cereal Carts, Runtz, Dr. Zodiac, Eureka, Supreme G, and CaliPlug were reported by 1%–5% of patients nationwide. Use of 134 other products were reported by <1% of hospitalized patients. † Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont. Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming. Puerto Rico and U.S. Virgin Islands were included in the South region.
See this image and copyright information in PMC

References

    1. Moritz ED, Zapata LB, Lekiachvili A, et al.; Lung Injury Response Epidemiology/Surveillance Group; Lung Injury Response Epidemiology/Surveillance Task Force. Update: characteristics of patients in a national outbreak of e-cigarette, or vaping, product use–associated lung injuries—United States, October 2019. MMWR Morb Mortal Wkly Rep 2019;68:985–9. 10.15585/mmwr.mm6843e1 - DOI - PMC - PubMed
    1. Chatham-Stephens K, Roguski K, Jang Y, et al.; Lung Injury Response Epidemiology/Surveillance Task Force; Lung Injury Response Clinical Task Force. Characteristics of hospitalized and nonhospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use–associated lung injury—United States, November 2019. MMWR Morb Mortal Wkly Rep 2019;68:1076–80. 10.15585/mmwr.mm6846e1 - DOI - PMC - PubMed
    1. Perrine CG, Pickens CM, Boehmer TK, et al.; Lung Injury Response Epidemiology/Surveillance Group. Characteristics of a multistate outbreak of lung injury associated with e-cigarette use, or vaping—United States, 2019. MMWR Morb Mortal Wkly Rep 2019;68:860–4. 10.15585/mmwr.mm6839e1 - DOI - PMC - PubMed
    1. Ghinai I, Pray IW, Navon L, et al. E-cigarette product use, or vaping, among persons with associated lung injury—Illinois and Wisconsin, April–September 2019. MMWR Morb Mortal Wkly Rep 2019;68:865–9. 10.15585/mmwr.mm6839e2 - DOI - PMC - PubMed
    1. Navon L, Jones CM, Ghinai I, et al. Risk factors for e-cigarette, or vaping, product use-associated lung injury (EVALI) among adults who use e-cigarette, or vaping, products—Illinois, July–October 2019. MMWR Morb Mortal Wkly Rep 2019;68:1034–9. 10.15585/mmwr.mm6845e1 - DOI - PMC - PubMed